Reaction
Monoclonal Immunoglobulin Increased reporting signals
As of the last recalculation, Monoclonal Immunoglobulin Increased appears in 279 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is IXAZOMIB (PRR 120.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ixazomib | 40 | 120.9 | 121.1 |
| Daratumumab | 42 | 92.2 | 92.2 |
| Melphalan | 15 | 51.9 | 52.0 |
| Carfilzomib | 18 | 50.7 | 50.7 |
| Bortezomib | 49 | 49.4 | 49.4 |
| Lenalidomide | 141 | 49.3 | 49.3 |
| Atovaquone | 5 | 47.2 | 47.2 |
| Melphalan Hydrochloride | 15 | 47.1 | 47.1 |
| Pomalidomide | 51 | 45.1 | 45.1 |
| Selinexor | 4 | 35.0 | 35.0 |